Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Dynora Rivera

Nurse Practitioner, Psychiatric/Mental Health Bethlehem, PA Nurse Practitioner

NPI 1528653375 CMS profile 11129225

2545 Schoenersville Rd, Fl Msouth5, Bethlehem, PA 18017

Open in the dashboard

General payments

$395

5 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dynora Rivera of Bethlehem, PA is reported in the CMS Open Payments database as having received $395 across 5 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $125 1
2023 General $29 2
2022 General $116 1
2021 General $125 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dynora Rivera
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Dynora Rivera were reported at $125. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Dynora Rivera Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $125 $166 $54–$482 $132
2022 $116 $195 $66–$559 $149
2023 $29 $233 $82–$673 $160
2024 $0 $236 $84–$688 $164
2025 $125 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Products, LP $241 2 payments
  2. ViiV Healthcare Company $125 1 payment
  3. Otsuka America Pharmaceutical, Inc. $29 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $395 5 payments
Products named General payments · program years 2021–2025
  1. SYMTUZA Infectious Diseases $125 1 payment
  2. SYMTUZA Infectious Diseases & Vaccines $116 1 payment
  3. ABILIFY ASIMTUFII $29 2 payments
  4. ABILIFY MAINTENA $29 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 34 drugs

Part D claims

1,668

Median for Nurse Practitioner: 389

Drug cost

$133,129

Median for Nurse Practitioner: $21,885

Branded share of claims

19.8%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Invega Sustenna Paliperidone Palmitate Brand 23 $46,378
Abilify Maintena Aripiprazole Brand 14 $37,674
Vivitrol Naltrexone Microspheres Brand 18 $28,518
Trintellix Vortioxetine Hydrobromide Brand 12 $5,612
Quetiapine Fumarate Generic 323 $1,969
Aripiprazole Generic 56 $1,672
Hydroxyzine Hcl Generic 123 $1,509
Bupropion Xl Bupropion Hcl Brand 120 $1,503
Mirtazapine Generic 102 $1,192
Olanzapine Generic 91 $844

The 10 drugs with the highest cost, of 34 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Records

5 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Psychiatric/Mental Health in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record